M. Trappoliere

605 total citations
9 papers, 493 citations indexed

About

M. Trappoliere is a scholar working on Epidemiology, Pharmacology and Hepatology. According to data from OpenAlex, M. Trappoliere has authored 9 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 4 papers in Pharmacology and 4 papers in Hepatology. Recurrent topics in M. Trappoliere's work include Liver Disease Diagnosis and Treatment (7 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Diet, Metabolism, and Disease (3 papers). M. Trappoliere is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Diet, Metabolism, and Disease (3 papers). M. Trappoliere collaborates with scholars based in Italy, Netherlands and Türkiye. M. Trappoliere's co-authors include C. Loguercio, Massimo Pinzani, Francesco Vizzutti, Fabio Marra, Alessandra Caligiuri, Cristiana Bertolani, Alessandro Federico, Paola Failli, Erica Novo and Giacomo Laffi and has published in prestigious journals such as Hepatology, Journal of Hepatology and Digestive Diseases and Sciences.

In The Last Decade

M. Trappoliere

9 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Trappoliere Italy 7 284 134 132 119 118 9 493
Federico Salamone Italy 6 260 0.9× 68 0.5× 148 1.1× 83 0.7× 117 1.0× 9 468
M.V. D’Auria Italy 6 430 1.5× 53 0.4× 104 0.8× 43 0.4× 185 1.6× 10 581
Hung‐Shang Tang Taiwan 11 266 0.9× 89 0.7× 217 1.6× 49 0.4× 33 0.3× 23 558
Mohamed H. Ahmed United Kingdom 11 338 1.2× 36 0.3× 88 0.7× 43 0.4× 184 1.6× 22 533
Fábio Pinatel Lopasso Brazil 11 177 0.6× 39 0.3× 79 0.6× 83 0.7× 72 0.6× 23 456
Alexander Smith United Kingdom 13 383 1.3× 77 0.6× 380 2.9× 29 0.2× 48 0.4× 22 821
Ashwani K. Singal United States 14 516 1.8× 75 0.6× 349 2.6× 86 0.7× 133 1.1× 31 824
Daniela Caterina Amoruso Italy 8 233 0.8× 42 0.3× 115 0.9× 35 0.3× 72 0.6× 13 519
Raúl Lazarte United States 4 364 1.3× 43 0.3× 86 0.7× 25 0.2× 164 1.4× 7 488
Emilio A. Rodríguez Garay Argentina 12 100 0.4× 152 1.1× 61 0.5× 49 0.4× 39 0.3× 52 533

Countries citing papers authored by M. Trappoliere

Since Specialization
Citations

This map shows the geographic impact of M. Trappoliere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Trappoliere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Trappoliere more than expected).

Fields of papers citing papers by M. Trappoliere

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Trappoliere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Trappoliere. The network helps show where M. Trappoliere may publish in the future.

Co-authorship network of co-authors of M. Trappoliere

This figure shows the co-authorship network connecting the top 25 collaborators of M. Trappoliere. A scholar is included among the top collaborators of M. Trappoliere based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Trappoliere. M. Trappoliere is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Trappoliere, M., Alessandra Caligiuri, Cristiana Bertolani, et al.. (2009). Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells. Journal of Hepatology. 50(6). 1102–1111. 191 indexed citations
2.
Vizzutti, Francesco, Umberto Arena, Valério Nobili, et al.. (2009). Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD). Annals of Hepatology. 8(2). 89–94. 32 indexed citations
3.
Trappoliere, M., A. Caligiuri, Cristiana Bertolani, et al.. (2008). Silybin is a direct antifibrogenic and antiinflammatory agent: Cellular and molecular mechanisms. Digestive and Liver Disease. 40(10). A127–A127. 5 indexed citations
4.
Caligiuri, Alessandra, Cristiana Bertolani, Cristina Tosti Guerra, et al.. (2007). Adenosine monophosphate–activated protein kinase modulates the activated phenotype of hepatic stellate cells. Hepatology. 47(2). 668–676. 113 indexed citations
5.
Loguercio, C., Alessandro Federico, M. Trappoliere, et al.. (2007). The Effect of a Silybin-Vitamin E-Phospholipid Complex on Nonalcoholic Fatty Liver Disease: A Pilot Study. Digestive Diseases and Sciences. 52(9). 2387–2395. 86 indexed citations
6.
Federico, Alessandro, M. Trappoliere, & C. Loguercio. (2006). Treatment of patients with non-alcoholic fatty liver disease: Current views and perspectives. Digestive and Liver Disease. 38(11). 789–801. 30 indexed citations
7.
Trappoliere, M., Concetta Tuccillo, Alessandro Federico, et al.. (2006). The treatment of NAFLD.. PubMed. 9(5). 299–304. 17 indexed citations
8.
Federico, Alessandro, M. Trappoliere, E. Coppola, et al.. (2006). 682 Relationship between dietary intake and liver histology in non-alcoholic fatty liver disease. Journal of Hepatology. 44. S251–S252. 1 indexed citations
9.
Trappoliere, M., Alessandro Di Federico, Concetta Tuccillo, et al.. (2005). [Effects of a new pharmacological complex (silybin + vitamin-E + phospholipids) on some markers of the metabolic syndrome and of liver fibrosis in patients with hepatic steatosis. Preliminary study].. PubMed. 51(2). 193–9. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026